Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 19-May-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 20)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-May-13 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
18-May-13 Pechala's Reports Frantisek Pechala GENTIUM SPA (GENT) 12-months forecast 1 $15 View Abstract
17-May-13 Thomson Reuters Stock Report StockReports + Research Department Thomson Reuters Stock Report - GENTING BERHAD (GENTING-KU) 11 $25 View Abstract
17-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-biomed/genetics 18 $207 View Abstract
16-May-13 S&P Capital IQ Quantitative Report N/A Gentium S.p.A. ADR 6 $69 View Abstract
16-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for GENT 11 $126.50 View Abstract
12-May-13 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: GENTIUM SPA -ADR 5 $10 View Abstract
11-May-13 Reuters Investment Profile N/A Genting Bhd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $138 View Abstract
5-May-13 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: GENTIUM SPA -ADR 5 $10 View Abstract
28-Apr-13 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: GENTIUM SPA -ADR 5 $10 View Abstract
Next 10

Independent Reports (Showing 1 to 10 of 20)

Release
Date Contributor Author Title Pages Price More Info
20-May-13 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
18-May-13 Pechala's Reports Frantisek Pechala GENTIUM SPA (GENT) 12-months forecast 1 $15 View Abstract
17-May-13 Thomson Reuters Stock Report StockReports + Research Department Thomson Reuters Stock Report - GENTING BERHAD (GENTING-KU) 11 $25 View Abstract
17-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-biomed/genetics 18 $207 View Abstract
16-May-13 S&P Capital IQ Quantitative Report N/A Gentium S.p.A. ADR 6 $69 View Abstract
16-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for GENT 11 $126.50 View Abstract
12-May-13 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: GENTIUM SPA -ADR 5 $10 View Abstract
11-May-13 Reuters Investment Profile N/A Genting Bhd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $138 View Abstract
5-May-13 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: GENTIUM SPA -ADR 5 $10 View Abstract
28-Apr-13 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: GENTIUM SPA -ADR 5 $10 View Abstract
Next 10

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.